Base to Base biotech podcast 56: GRIN genes and relapsing MS
Positive first-in-human data for IVF-related embryo implantation failure treatment
New company plans to replace daily injections with implant
UCB adds epilepsy drug through Neurona Therapeutics acquisition
Base to Base biotech podcast 6: Persica Pharmaceuticals and Caszyme
Base to Base biotech podcast 5: Vitalant’s vital role in blood products, and Brainomix gives hope to stroke victims
Base to Base biotech podcast 4: A new class of therapeutics, and biotech hiring in 2025
Base to Base biotech podcast 3: Nanoparticles and Duchenne muscular dystrophy
Canadian university researchers discover new class of antibiotics
Base to Base biotech podcast 2: Opioid alternatives and epiproteomics
Base to Base biotech podcast 1: Osteoboost and Pheast Therapeutics
SXSW announces 2025 pitch competition finalists